IP Library › Assignment 032368/0099
Patent Assignment
Reel/Frame 032368/0099

Merger

Recorded: 2014-03-06 Pages: 9
Assignors
APEX MERGER SUB, INC.
Executed: 2009-04-17
CV THERAPEUTICS, INC.
Executed: 2009-04-17
Assignee
GILEAD PALO ALTO, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA, 94404-1147
Covered Property (1)
N-Pyrazole A2A Receptor Agonists
Patent: 7,655,637 →
Application: 11/588,834 →
Publication: US 2007/0203090
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Apr 16, 2008
From: CV THERAPEUTICS, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 020808/0823 →
Merger Oct 6, 2009
From: GILEAD PALO ALTO, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 023330/0648 →
Assignment of Assignor's Interest Jan 6, 2010
From: TPG-AXON ROYALTY TRUST
To: TPG-AXON LEX SUB-TRUST
Reel/Frame 023731/0916 →
Assignment of Assignor's Interest Jun 10, 2011
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 026424/0925 →
Assignment of Assignor's Interest Mar 4, 2014
From: ZABLOCKI, JEFF A.; PALLE, VENKATA P.; ELZEIN, ELFAITH O.; BELARDINELLI, LUIZ
To: CV THERAPEUTICS, INC.
Reel/Frame 032347/0812 →